[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]

Onkologie. 1987 Oct;10(5):321-3. doi: 10.1159/000216433.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Aminoglutethimide / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Cortisone / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Medroxyprogesterone / analogs & derivatives*
  • Medroxyprogesterone / therapeutic use
  • Medroxyprogesterone Acetate
  • Neoplasm Metastasis
  • Random Allocation

Substances

  • Antineoplastic Agents
  • Aminoglutethimide
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone
  • Cortisone